insights_auto
Why is GALT up 5.19%?
Dive Deeperchevron_right
GALT:NASDAQ
Galectin Therapeutics Inc. Common Stock
$3.14
arrow_upward
+5.19%(+0.16) 1D
Nov 6, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GALT...
Open
$3.01
High
$3.18
Low
$2.90
Mkt. cap
316.14M
Avg. vol.
206.20K
Volume
223.44K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
Open
$3.01
High
$3.18
Low
$2.90
Mkt. cap
316.14M
Avg. vol.
206.20K
Volume
223.44K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
News stories
From web sources and news partners
BigGo Finance
·
57 minutes ago
Nasdaq Slides Into Correction as Fear Gauge Hits 'Extreme Fear'; Buffett's Crisis Playbook Back in Focus
TheStreet
·
11 minutes ago
Why S&P 500 investors may want to look beyond mega-cap tech
Binance
·
44 minutes ago
TradFi News | Nasdaq Drops 3.4% in Week as AI Chip Stocks Slump; Berkshire Posts Record $9.6 Billion Buyback
Yahoo Finance
·
5 hours ago
Coca-Cola (KO) Makes the Dow’s Low-Upside List While Selling More Drinks, Not Just Charging More
About Galectin Therapeutics Inc. Common Stock
CEO-
Employees9
Founded2000
HeadquartersNorcross, Georgia, United States
SectorHealth Care
IndustryBiotechnology
Websitegalectintherapeutics.com